Validation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-moderated Assessment
ZS Associates
1,000 participants
Feb 26, 2025
OBSERVATIONAL
Conditions
Summary
This study expands and validates the pilot study NCT06381284. It is a fully remote, site-less, prospective, observational study enrolling adults in the United States (excluding U.S. territories) with undiagnosed neuromuscular symptoms. The primary objective is to determine the validity of a self-assessment tool in encouraging undiagnosed participants, recruited through a social media campaign, to seek medical evaluation for suspected myasthenia gravis (MG).
Eligibility
Inclusion Criteria4
- Reside within the 50 states of the United States at the time of enrollment
- Age 19 or older if reside in Nebraska or Alabama, Age 21 or older if reside in Mississippi, Age 18 years or older if reside in any other state
- Active email account
- Fluency in English (spoken / written), as demonstrated by the ability to read and sign the Informed Consent Form
Exclusion Criteria5
- Live in an overseas territory of the United States
- Inability or unwillingness to provide written informed consent
- Diagnosed myasthenia gravis, including sero-negative MG*
- Diagnosed multiple sclerosis
- Have speech impairment, eye/arm/leg weakness due to diagnosed brain cancer, or stroke
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Social media users exposed to a variety of paid social media advertisements as a recruitment tool for study enrollment
Eligible participants are asked to complete self-administered physical tests to assess inducible fatigue of specific muscle groups
Patients triaged based on their assessed risk of MG are asked to complete recommended follow-up with a clinician to determine presence of myasthenia gravis
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06866483